Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF
Articolo
Data di Pubblicazione:
2018
Abstract:
Hyperkalaemia is a common co-morbidity in patients with heart failure with reduced ejection fraction (HFrEF). Whether it affects the use of renin-angiotensin-aldosterone system inhibitors and thereby negatively impacts outcome is unknown. Therefore, we investigated the association between potassium and uptitration of angiotensin-converting enzyme inhibitors (ACEi)/angiotensin receptor blockers (ARB) and its association with outcome.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Guideline-directed medication; Heart failure; Hyperkalaemia; Outcome; Renin-angiotensin-aldosterone system inhibitors
Elenco autori:
Beusekamp, Joost C; Tromp, Jasper; van der Wal, Haye H; Anker, Stefan D; Cleland, John G; Dickstein, Kenneth; Filippatos, Gerasimos; van der Harst, Pim; Hillege, Hans L; Lang, Chim C; Metra, Marco; Ng, Leong L; Ponikowski, Piotr; Samani, Nilesh J; van Veldhuisen, Dirk J; Zwinderman, Aeilko H; Rossignol, Patrick; Zannad, Faiez; Voors, Adriaan A; van der Meer, Peter
Link alla scheda completa:
Pubblicato in: